Dr. Ashok Ramalingam, MD

Dr. Ramalingam practices at Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation.

Dr. Ramalingam's NPI, 1184605255, was assigned on November 7, 2005. Dr. Ramalingam graduated from Northeastern Ohio University College of Medicine in 1999. Dr. Ramalingam holds Ohio license 35-084245.

Dr. Ramalingam's primary practice is Cleveland Clinic Akron General, at 1 Akron General Avenue, Akron, OH 44307 in Summit County. The practice phone is (330) 344-6000.

Dr. Ramalingam's primary practice is Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation. Dr. Ramalingam is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Ramalingam to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramalingam practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Ramalingam's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Ramalingam is licensed in Ohio.

CMS data shows 1,875 Medicare services from Dr. Ramalingam across 19 procedure codes in 2024, for 243 Medicare patients. Medicare paid $128,281 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 243 Medicare patients who saw Dr. Ramalingam in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ramalingam's median patient age at 70, with 33% women.

In 2024, Dr. Ramalingam wrote 347 Medicare Part D claims for 117 patients. 75% of them were for generic drugs. CMS names the drug for 269 of them, across 6 drugs with 11 or more claims each, at $201,987 in total drug cost. In 2023, CMS named 124 claims across 3 drugs.

Dr. Ramalingam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ramalingam as offering telehealth.

Dmand AI links 1 paper to Dr. Ramalingam in 2018. Dr. Ramalingam's most frequent co-authors are Lawrence Bruce Berk, MD, James E. Clarkson, MD and William Fitzgerald Demas, MD.

Dmand AI links Dr. Ramalingam to 5 clinical trials, 4 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Small Cell Lung Carcinoma. NRG Oncology sponsors the most, 3.

CMS Open Payments shows 1 general payment to Dr. Ramalingam from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Augmenix, Inc. paid the most, $120.

Dr. Ramalingam graduated from Northeastern Ohio University College of Medicine in 1999.